Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tea time: can your cup of tea control blood sugar?

NCT ID NCT07609004

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how different types of tea change blood sugar and insulin levels after eating. Twenty healthy Chinese men will drink tea alone or with a standard meal, and their blood will be tested over three hours. The goal is to understand how tea affects the body's response to food, not to treat or cure any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 60 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male * Chinese ethnicity * Ages 21-60 years old (inclusive) * Healthy * Weigh at least 50kg * Must be English-literate and able to give informed consent in English * Reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures Exclusion Criteria: * Female * A current smoker, or has smoked in the past 2 years * Fasting glucose \>= 7 mmol/L * History of type 1/type 2 diabetes * Regular use of medication that may affect glucose metabolism (e.g., steroids) * Being diagnosed with cancer, heart disease, stroke, renal failure, serious mental or physical illnesses at the time of recruitment * History of food allergies to test products (milk tea) i.e. milk allergies, or lactose intolerance * History of food allergies to any of the ready made meals (such as soy, peanuts, eggs, shellfish etc) * Have donated blood of more than 500 mL within 8 weeks of study enrolment * Any other conditions, which, in the opinion of the Investigator would make the subject unsuitable for inclusion or could interfere with the subject participating in or completing the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Glycaemic response are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National University of Singapore, Department of Food Science & Technology

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.